Literature DB >> 16980152

Kaplan-Meier methods yielded misleading results in competing risk scenarios.

Danielle A Southern1, Peter D Faris, Rollin Brant, P Diane Galbraith, Colleen M Norris, Merril L Knudtson, William A Ghali.   

Abstract

BACKGROUND AND
OBJECTIVE: Time-to-event curves are routinely presented in the medical literature. The most widely used method is the Kaplan-Meier (K-M) method, but this analysis approach may not be appropriate when an analysis focuses on time-to-first event in scenarios where there are competing events. We compared K-M methods applying various censoring approaches with the lesser-known "cumulative incidence competing risks" (CICR) method in an analysis of competing events.
METHODS: A registry containing data on 21,624 patients undergoing cardiac catheterization was analyzed. Time to coronary artery bypass grafting (CABG) was assessed in an analysis for which percutaneous coronary intervention and death were competing events. Time-to-CABG curves were calculated using the "K-M censor all method," "K-M censor death only method," "K-M ignore all method," and the CICR method.
RESULTS: One-year CABG rates calculated for the K-M "censor all," "censor death only," and "ignore all" methods were 28.8%, 22.8%, and 22.4%, respectively compared to the "actual" rate of 20.8%. For the CICR method, the corresponding 1-year rate was identical to the "actual" rate.
CONCLUSION: In situations with competing risks, and where an analysis focuses on first events, the CICR method is most appropriate, as K-M methods will tend to overestimate event rates.

Entities:  

Mesh:

Year:  2006        PMID: 16980152     DOI: 10.1016/j.jclinepi.2006.07.002

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  46 in total

1.  Revision surgery and mortality following complex spine surgery: 2-year follow-up in a prospective cohort of 679 patients using the Spine AdVerse Event Severity (SAVES) system.

Authors:  Tanvir Johanning Bari; Sven Karstensen; Mathias Dahl Sørensen; Martin Gehrchen; John Street; Benny Dahl
Journal:  Spine Deform       Date:  2020-06-30

2.  Competing risk of death: an important consideration in studies of older adults.

Authors:  Sarah D Berry; Long Ngo; Elizabeth J Samelson; Douglas P Kiel
Journal:  J Am Geriatr Soc       Date:  2010-03-22       Impact factor: 5.562

Review 3.  Kaplan-Meier Survival Analysis Overestimates the Risk of Revision Arthroplasty: A Meta-analysis.

Authors:  Sarah Lacny; Todd Wilson; Fiona Clement; Derek J Roberts; Peter D Faris; William A Ghali; Deborah A Marshall
Journal:  Clin Orthop Relat Res       Date:  2015-11       Impact factor: 4.176

4.  Background and design of the symptom burden in end-stage liver disease patient-caregiver dyad study.

Authors:  Lissi Hansen; Karen S Lyons; Nathan F Dieckmann; Michael F Chang; Shirin Hiatt; Emma Solanki; Christopher S Lee
Journal:  Res Nurs Health       Date:  2017-06-30       Impact factor: 2.228

5.  Prognostic factors in Asian and white American patients with cervical cancer, considering competing risks.

Authors:  Y Hou; S Guo; J Lyu; Z Lu; Z Yang; D Liu; Z Chen
Journal:  Curr Oncol       Date:  2019-06-01       Impact factor: 3.677

6.  Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching.

Authors:  Anat Fisher; Greg Carney; Ken Bassett; Colin R Dormuth
Journal:  Drugs Aging       Date:  2017-03       Impact factor: 3.923

7.  Engaging foster parents in treatment: a randomized trial of supplementing trauma-focused cognitive behavioral therapy with evidence-based engagement strategies.

Authors:  Shannon Dorsey; Michael D Pullmann; Lucy Berliner; Elizabeth Koschmann; Mary McKay; Esther Deblinger
Journal:  Child Abuse Negl       Date:  2014-04-29

Review 8.  Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective.

Authors:  John L Moran; Petra L Graham; Sue Rockliff; Andrew D Bersten
Journal:  Crit Care       Date:  2010-07-13       Impact factor: 9.097

9.  Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.

Authors:  Jeffrey J Tosoian; Mufaddal Mamawala; Jonathan I Epstein; Patricia Landis; Sacha Wolf; Bruce J Trock; H Ballentine Carter
Journal:  J Clin Oncol       Date:  2015-08-31       Impact factor: 44.544

10.  Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy.

Authors:  Tatjana I Jung; Falk Hoffmann; Gerd Glaeske; Dieter Felsenberg
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-22       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.